Faculty Opinions recommendation of Evaluation of the addition of rituximab to CODOX-M/IVAC for Burkitt's lymphoma: a retrospective analysis.
1990 ◽
Vol 48
(7)
◽
pp. 708-713
◽
Keyword(s):
1986 ◽
Vol 15
(1)
◽
pp. 205-217
◽
Keyword(s):
Keyword(s):